{"id":12059,"date":"2024-11-07T17:42:57","date_gmt":"2024-11-07T15:42:57","guid":{"rendered":"https:\/\/adragos-pharma.com\/?p=12059"},"modified":"2025-07-09T12:35:36","modified_gmt":"2025-07-09T10:35:36","slug":"project-future-new-production-line-launched-at-livron-facility","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/project-future-new-production-line-launched-at-livron-facility\/","title":{"rendered":"Project Future: New Production Line Launched at Livron Facility"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">We are <strong>thrilled to announce the launch of our cutting-edge ampoule filling line at Adragos&#8217; Livron facility in France, marking a transformative milestone in Project Future.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This new line is a major investment in enhancing production capacity and furthering our commitment to quality and compliance. This new line increases our production capacity to over 160 million ampoules per year, with flexible fill volumes ranging from 1ml to 20ml. This addition underscores our dedication to meeting rising demand while exceeding regulatory standards and client expectations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In May, Adragos\u2019 Board members visited Livron to see the nearly completed line and were impressed by the facility\u2019s transformation and the team\u2019s dedication. The line is now fully operational within our newly renovated main building, positioning Adragos to lead in high-quality ampoule manufacturing.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/11\/SMoraud-Vepres-Haupt-Pharma-230424-5173-1024x683.jpg\" alt=\"new filling line Livron\" class=\"wp-image-14140\" srcset=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/11\/SMoraud-Vepres-Haupt-Pharma-230424-5173-1024x683.jpg 1024w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/11\/SMoraud-Vepres-Haupt-Pharma-230424-5173-300x200.jpg 300w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/11\/SMoraud-Vepres-Haupt-Pharma-230424-5173-768x512.jpg 768w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/11\/SMoraud-Vepres-Haupt-Pharma-230424-5173.jpg 1500w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">With this fourth filling line, <strong>we\u2019ve expanded capacity by 30%, fully meeting the regulatory requirements.<\/strong><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">This new line also directly benefits our clients, as our CCO, Marco Gorgas emphasized: \u201c<em>We are always attentive to our customers\u2019 needs to better serve their patients. We recognized not only a regulatory demand in Annex 1 but also an urgent need for greater capacity, particularly for larger-volume ampoules. That\u2019s why we installed this fourth line, allowing us to offer a capacity of over 160 million ampoules, including options up to 20ml, tailored to serve our clients\u2019 evolving requirements<\/em>.\u201d<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">One of Project Future&#8217;s greatest achievements was navigating the structural challenges of our historic Livron site, which dates back to 1918.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"728\" src=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/09\/livron-temoignage-2-1024x728.jpg\" alt=\"Gael Le Saux, Site Head Livron facility\" class=\"wp-image-12062\" srcset=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/09\/livron-temoignage-2-1024x728.jpg 1024w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/09\/livron-temoignage-2-300x213.jpg 300w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/09\/livron-temoignage-2-768x546.jpg 768w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/09\/livron-temoignage-2-1536x1092.jpg 1536w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2024\/09\/livron-temoignage-2.jpg 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">As Ga\u00ebl Le Saux, Site Head of Livron, explained: \u201cWith the site&#8217;s origins dating back to 1918, structural constraints presented considerable challenges. However, the team adapted brilliantly, raising the roof and rebuilding key areas to fit the new cleanroom, all while keeping operations seamless. The management of this project\u2019s complexity was truly exemplary.\u201d<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">Today, <strong>November 7th, we celebrate the official inauguration of the new ampoule filling line at our Livron facility. <\/strong>This special event brings together Adragos\u2019 executive team, the mayor of Livron-sur-Dr\u00f4me, local journalists, and our dedicated employees who have been integral to this project\u2019s success. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This celebration is a testament to our team&#8217;s hard work and dedication and marks a new chapter of growth, innovation, and excellence for Adragos. We look forward to the new achievements and client partnerships this line will enable and are excited about the bright future ahead.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>We are thrilled to announce the launch of our cutting-edge ampoule filling line at Adragos&#8217; Livron facility in France, marking a transformative milestone in Project Future. This new line is a major investment in enhancing production capacity and furthering our [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":12068,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[12],"tags":[],"topics":[],"locations":[41],"experts":[],"class_list":["post-12059","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","locations-livron"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/12059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/comments?post=12059"}],"version-history":[{"count":11,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/12059\/revisions"}],"predecessor-version":[{"id":19968,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/12059\/revisions\/19968"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media\/12068"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media?parent=12059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/categories?post=12059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/tags?post=12059"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/topics?post=12059"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/locations?post=12059"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/experts?post=12059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}